GMP Manufacturing Capabilities

Little Green Pharma has an exclusive agreement with our Manufacturing Partner, a fully licensed TGA GMP-certified pharmaceutical manufacturing company in Western Australia, to manufacture final dose form cannabis medicines on our behalf.

All Little Green Pharma’s medicinal cannabis products are manufactured in accordance with applicable GMP guidelines in facilities audited and licensed by the Therapeutic Goods Administration (TGA). Our Manufacturing Partner’s GMP licensing is recognised by EU regulatory authorities as meeting EU-GMP standards, enabling LGP to import and sell medicinal cannabis products into the EU. Our Manufacturing Partner is licensed to produce oil, gel cap, suppository, emulsion, and spray products, and is anticipated to begin manufacturing dry cannabis flower in late 2020. Little Green Pharma also anticipates introducing new delivery systems into its product range as the market develops. In October, Little Green Pharma was granted a Therapeutic Goods Administration (TGA) Good Manufacturing Practices (GMP) licence for its newly commissioned manufacturing facility in Western Australia. This license means:

  • LGP will now be able to produce medicinal cannabis flower products
  • LGP has the benefit of enhanced manufacturing capacity in addition to our existing pharmaceutical manufacturer strong supply reliability for patients

The GMP licencing of the Company’s manufacturing facility is the culmination of a two-year regulatory strategy. Little Green Pharma now holds over 20 State and Federal operating authorisations, allowing it to operate a fully in-house and vertically-integrated cannabis cultivation, production, manufacturing, and wholesaling supply chain, capable of supplying various LGP branded medicinal cannabis products into Australian and international markets. The manufacturing facility was constructed with funding support from the West Australian Government and represents a regional manufacturing success story for South West Western Australia.